Telix Pharmaceuticals reported AUD568.21M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Cochlear AUD 1.87B 27.1M Dec/2024
CSL USD 20.55B 3.18B Dec/2024
Integral Diagnostics AUD 301.71M 1.33M Jun/2024
Mayne Pharma AUD 454.19M 93.58M Jun/2024
Medical Developments International AUD 55.33M 9.6M Dec/2024
Mesoblast 480.35M 28.38M Jun/2024
Neuren Pharmaceuticals AUD 363.9M 144.75M Dec/2024
Pacific Edge NZD 26.08M 14.57M Mar/2025
Paradigm Biopharmaceuticals AUD 34.06M 10.25M Dec/2024
Polynovo AUD 72.12M 3.07M Jun/2024
PYC Therapeutics AUD 55.44M 25.62M Dec/2024
Ramsay Health Care AUD 4.81B 82.9M Dec/2024
ResMed USD 5.97B 714.85M Jun/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024